209 related articles for article (PubMed ID: 30843133)
1. Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
Vigano L; Soldani C; Franceschini B; Cimino M; Lleo A; Donadon M; Roncalli M; Aghemo A; Di Tommaso L; Torzilli G
J Gastrointest Surg; 2019 Nov; 23(11):2216-2224. PubMed ID: 30843133
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of stromal tumor-infiltrating lymphocytes in intrahepatic cholangiocarcinoma: a population-based study.
Qiang Z; Dai K; He Y; Yang Z; Tao L; Zhang H; Yu H
Scand J Gastroenterol; 2022 Aug; 57(8):965-971. PubMed ID: 35522155
[TBL] [Abstract][Full Text] [Related]
4. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
5. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.
Yamamoto Y; Shimada K; Sakamoto Y; Esaki M; Nara S; Ban D; Kosuge T; Ojima H
J Surg Oncol; 2009 Mar; 99(3):161-5. PubMed ID: 19101954
[TBL] [Abstract][Full Text] [Related]
7. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
[TBL] [Abstract][Full Text] [Related]
8. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
[TBL] [Abstract][Full Text] [Related]
11. Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.
Zhang XF; Bagante F; Chakedis J; Moris D; Beal EW; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1841-1850. PubMed ID: 28744741
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
13. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
14. Prognosis analysis of sarcomatous intrahepatic cholangiocarcinoma from a review of the literature.
Watanabe G; Uchinami H; Yoshioka M; Nanjo H; Yamamoto Y
Int J Clin Oncol; 2014; 19(3):490-6. PubMed ID: 23824556
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
[TBL] [Abstract][Full Text] [Related]
16. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
Huang S; Song JL; Li B; Yi PS; Yang J
BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
[TBL] [Abstract][Full Text] [Related]
19. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.
Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1888-1897. PubMed ID: 28840497
[TBL] [Abstract][Full Text] [Related]
20. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
